Comparison of continuous and intermittent IV infusion of vancomycin: Systematic review

Canadian Journal of Hospital Pharmacy

Volumn 63, Issue 5, 2010, Pages 373-381

  Man, Sally S K ^a   Carr, Roxane R ^b   Ensom, Mary H H ^b,c  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

Continuous infusion; Intermittent infusion; Vancomycin

Indexed keywords

VANCOMYCIN;

ARTICLE; CONTINUOUS INFUSION; EVIDENCE BASED PRACTICE; GRAM POSITIVE INFECTION; MEDLINE; RATING SCALE;

EID: 84055197875     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: 10.4212/cjhp.v63i5.949     Document Type: Article

References (20)

1. Roberts JA, Lipman J, Blot S, Rello J. Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients? Curr Opin Crit Care 2008;14(4):390-396.
2. Geraci JE. Vancomycin. Mayo Clin Proc 1977;52(10):631-634. (Pubitemid 8204614)
3. Rybak MJ, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009;66(1):82-98. Erratum in: Am J Health Syst Pharm 2009;66(10):887.
4. Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 2006;166(19):2138-2144. (Pubitemid 44631403)
5. Leader WG, Chandler MH, Castiglia M. Pharmacokinetic optimisation of vancomycin therapy. Clin Pharmacokinet 1995;28(4):327-342.
6. Watanabe T, Ohashi K, Matsui K, Kubota T. Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1997;39(4):471-476. (Pubitemid 27196944)
7. Wysocki M, Thomas F, Wolff MA, Pean Y, Ravaud Y, Herman B. Comparison of continuous with discontinuous intravenous infusion of vancomycin in severe MRSA infections. J Antimicrob Chemother 1995;35(2):352-354.
8. Wysocki M, Delatour F, Faurisson F, Rauss A, Pean Y, Misset B, et al. Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study. Antimicrob Agents Chemother 2001;45(9):2460-2467. (Pubitemid 32801896)
9. Byl B, Jacobs F, Wallemacq P, Rossi C, de Francquen P, Cappello M, et al. Vancomycin penetration of uninfected pleural fluid exudate after continuous or intermittent infusion. Antimicrob Agents Chemother 2003;47(6):2015-2017. (Pubitemid 36637836)
10. Ronchera-Oms CL, Gregorio S, Sanllehí N. Should continuous infusion of β-lactam antibiotics be the first-line approach? J Clin Pharm Ther 1997;22(3):159-161. (Pubitemid 28023196)
11. U.S. Preventive Services Task Force. Guide to clinical preventive services: report of the U.S. Preventive Services Task Force. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996.
12. James JK, Palmer SM, Levine DP, Rybak MJ. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections. Antimicrob Agents Chemother 1996;40(3):696-700. (Pubitemid 26071537)
13. Klepser M, Patel K, Nicolau DP, Quintiliani R, Nightingale CH. Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. Pharmacotherapy 1998;18(5):1069-1074. (Pubitemid 28439992)
14. Vuagnat A, Stern R, Lotthe A, Schuhmacher H, Duong M, Hoffmeyer P, et al. High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion. J Clin Pharm Ther 2004;29(4):351-357. (Pubitemid 39062165)
15. El Amari EB, Vuagnat A, Stern R, Assal M, Denormandie P, Hoffmeyer P, et al. High versus standard dose vancomycin for osteomyelitis. Scand J Infect Dis 2004;36(10):712-717. (Pubitemid 39467935)
16. Barois A, Estournet B, Moranne JB, Piliot J, Chabenat C, Bataille J. [Ventricular staphylococcal infections. Treatment with vancomycin by continuous venous infusion]. Presse Med 1986;15(36):1805-1808. Article in French.
17. Di Filippo A, De Gaudio AR, Novelli A, Paternostro E, Pelagatti C, Livi P, et al. Continuous infusion of vancomycin in methicillin-resistant staphylococcus infection. Chemotherapy 1998;44(1):63-68. (Pubitemid 28009177)
18. Matthews Z. Vancomycin continuous infusion: a cohort of 23 intensive care unit patients. Aust J Hosp Pharm 2001;31(2):108-110. (Pubitemid 32624733)
19. Sivagnanam S, Deleu D. Red man syndrome. Crit Care 2003;7(2):119-120. (Pubitemid 36432668)
20. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al.; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345(19):1368-1377.